Conference
Dose-Finding Study Of Once-Daily Treatment With Olodaterol, A Novel Long-Acting B2-Agonist, In Patients With Asthma
Authors
O'Byrne PM; D’Urzo T; Gahlemann M; Hart L; Wang F; Beck E
Pagination
pp. a3963-a3963
Publisher
American Thoracic Society
Publication Date
May 2012
DOI
10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a3963
Name of conference
C22. ASTHMA THERAPY